EarliTec Diagnostics, Inc.

About

EarliPoint Health is a digital health company dedicated to improving autism care through early diagnosis and treatment. Founded on extensive NIH-backed research by autism expert Dr. Ami Klin, the company rebranded from EarliTec Diagnostics in October 2025. Headquartered in Atlanta, Georgia, EarliPoint Health focuses on a comprehensive care ecosystem that emphasizes early diagnosis, timely treatment, and outcome measurement for children with autism spectrum disorder (ASD). The core product, the EarliPoint System, is an FDA-cleared medical device designed to assist in the diagnosis and assessment of ASD in children aged 16 to 30 months. It features an eye-tracking device that uses age-appropriate videos, a web portal for managing patient data, and AI software that analyzes social-visual engagement. The system aims to streamline the diagnosis-to-treatment process and enhance clinical workflows. Additionally, the EarliPoint Network connects families with autism service providers to facilitate evaluations and improve treatment access.